References
1. Yin H, Flynn AD. Drugging Membrane Protein Interactions. Annu Rev Biomed Eng . 2016;18(1):51-76. doi:10.1146/annurev-bioeng-092115-025322
2. Lu R-M, Hwang Y-C, Liu I-J, et al. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci . 2020;27(1):1. doi:10.1186/s12929-019-0592-z
3. Keizer RJ, Huitema ADR, Schellens JHM, Beijnen JH. Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies: Clinical Pharmacokinetics . 2010;49(8):493-507. doi:10.2165/11531280-000000000-00000
4. Smith G. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science . 1985;228(4705):1315. doi:10.1126/science.4001944
5. Scott J, Smith G. Searching for peptide ligands with an epitope library. Science . 1990;249(4967):386. doi:10.1126/science.1696028
6. Marks J, Hoogenboom H, Griffiths A, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage.J Mol Biol . 1991;222(3):581-597.
7. Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nature Biotechnology . 1997;15(6):553-557. doi:10.1038/nbt0697-553
8. Feldhaus MJ, Siegel RW, Opresko LK, et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nature Biotechnology . 2003;21(2):163-170. doi:10.1038/nbt785
9. Steinwand M, Droste P, Frenzel A, Hust M, Dübel S, Schirrmann T. The influence of antibody fragment format on phage display based affinity maturation of IgG. mAbs . 2014;6(1):204-218. doi:10.4161/mabs.27227
10. Bradbury ARM, Sidhu S, Dübel S, McCafferty J. Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol . 2011;29(3):245-254. doi:10.1038/nbt.1791
11. Arslan M, Karadağ D, Kalyoncu S. Protein engineering approaches for antibody fragments: directed evolution and rational design approaches.Turk J Biol . 2019;43:1-12. doi:10.3906/biy-1809-28
12. Razai A, Garcia-Rodriguez C, Lou J. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol . 2005;351(1):158-169. doi:10.1016/j.jmb.2005.06.003
13. Pershad K, Pavlovic J, Gräslund S. Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display.Protein Eng Des Sel . 2010;23(4):279-288. doi:10.1093/protein/gzq003
14. Hutchings CJ, Koglin M, Marshall FH. Therapeutic antibodies directed at G protein-coupled receptors. mAbs . 2010;2(6):594-606. doi:10.4161/mabs.2.6.13420
15. Hutchings C, Colussi P, Clark T. Ion channels as therapeutic antibody targets. mAbs . 2019;11(2):265-296. doi:10.1080/19420862.2018.1548232
16. Knowles TJ, Finka R, Smith C, Lin Y-P, Dafforn T, Overduin M. Membrane Proteins Solubilized Intact in Lipid Containing Nanoparticles Bounded by Styrene Maleic Acid Copolymer. J Am Chem Soc . 2009;131(22):7484-7485. doi:10.1021/ja810046q
17. Rouck JE, Krapf JE, Roy J, Huff HC, Das A. Recent advances in nanodisc technology for membrane protein studies (2012-2017). FEBS Lett . 2017;591(14):2057-2088. doi:10.1002/1873-3468.12706
18. Tillotson BJ, Cho YK, Shusta EV. Cells and cell lysates: A direct approach for engineering antibodies against membrane proteins using yeast surface display. Methods . 2013;60(1):27-37. doi:10.1016/j.ymeth.2012.03.010
19. Yang Z, Wan Y, Tao P, et al. A cell–cell interaction format for selection of high-affinity antibodies to membrane proteins. Proc Natl Acad Sci USA . 2019;116(30):14971-14978. doi:10.1073/pnas.1908571116
20. Lown PS, Hackel BJ. Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast. ACS Comb Sci . Published online April 13, 2020. doi:10.1021/acscombsci.0c00036
21. Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display.Nat Protoc . 2006;1(2):755-768. doi:10.1038/nprot.2006.94
22. Kelly RL, Zhao J, Le D, Wittrup KD. Nonspecificity in a nonimmune human scFv repertoire. MAbs . 2017;9(7):1029-1035. doi:10.1080/19420862.2017.1356528
23. Stern LA, Schrack IA, Johnson SM, et al. Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panning: Geometry and Expression Drive Yeast Biopanning.Biotechnol Bioeng . 2016;113(11):2328-2341. doi:10.1002/bit.26001
TABLE 1 Anti-PD-L1 scFv equilibrium binding affinities measured on yeast